Month: January 2023

REGENATIVE LABS AND DR. MICHAEL LAVOR ANNOUNCE CASE STUDY DEMONSTRATING

NOVEL APPLICATION OF UMBILICAL CORD FLOWABLE TISSUE ALLOGRAFTS IN DECUBITUS ULCERS

NEWS PROVIDED BY Regenative Labs

 

PENSACOLA, Fla., Jan. 23, 2023 /PRNewswire/ — A case study analysis of two patients has been presented by Regenative Labs (Regenative), a leading HCT/P manufacturer, in collaboration with Dr. Michael Lavor of Saguaro Surgical. This case study demonstrates the use of Wharton’s Jelly, a connective tissue, allografts in combination with standard of care wound practices to accelerate the healing of refractory, Stage IV sacral wounds in paralyzed patients.

 

In reference to what he’s seen in the patient population regarding Wharton’s Jelly allografts, Lavor shared, “the patients have begged for more because it is the only thing that has helped them. I believe this is an excellent step prior to surgery, and will save hundreds of thousands of dollars.”

 

This case study demonstrates an application of Wharton’s Jelly allografts in late-stage sacral decubitus ulcers (SDU), also known as pressure sores, with associated tunneling in combination with standard of care. In the future, research may focus on the frequency and combination of procedural techniques that most efficiently promote granulation tissue formation and volumetric contracture of deep wounds with Wharton’s Jelly allografts.

 

“This, for wounds, is excellent for closing tunnels,” explained Dr. Lavor.

 

It was reported that for the first time in ten years, one patient experienced a highly accelerated wound closure rate, and observed volumetric reduction in the wound bed, healthy granulation tissue, and the resolution of deep tunneling. One patient achieved full one closure and epithelization.

 

Both patients in the presented case study had SDU classified as Stage IV with tissue loss and bone or tendon involvement. One patient had previously experienced a mid-sacral pressure sore with exposed tendon, bone, and tunneling for ten years. The other, had an ischial pressure sore with the same features that persisted for 30 months. After failing multiple conservative treatments such as wound vac placement, antibiotics, wet-to-dry dressings, and silver sulfadiazine dressings, both patients received several applications of Regenative’s Wharton’s Jelly allograft.

 

In both cases, after eight months of standardized wound care treatment combined with six applications of Regenative’s Wharton’s Jelly allograft, the wounds contracted by over 90% in depth, tunneling, and diameter.

 

Annually, thousands of individuals are affected by SDU. Treatment for these conditions is costly and far from perfect, with prices as high as an eye-watering 240,000 dollars for skin flap surgery. Inevitably, Stage II pressure ulcers can become serious if not handled swiftly. When deep, tunneling, and with both tendon and bone involvement, such as the two patients in this case study, late-stage pressure sores occur, and pose a great challenge to medical professionals.

 

Regenative is committed to providing patients with alternative options, and through what may be revealed in these studies, offering proven treatments to better address the root cause of their pain.

 

Regenative hopes to enlist physicians to take part in studies regarding uncovered uses. Physicians will have their outcomes highlighted, furthering the understanding of regenerative medicine and uncovering new applications for this groundbreaking field of medicine.

 

“The research at Regenative is very promising, and we’re calling on physicians across the country to engage with us and advance regenerative medicine,” shared Regenative Labs CEO, Tyler Barrett.

 

Contact Regenative to get your practice involved today.

 

About Regenative Labs: Regenative Labs produces regenerative medicine products to address the root cause of a patient’s conditions using Wharton’s Jelly innovations rather than masking the pain with other treatments. Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development. Formed by veteran industry professionals familiar with the daily challenges of innovations in healthcare, the company provides non-addictive, non-invasive options for patients. Regenative Labs’ expert product research and development team comply with FDA guidelines of minimal manipulation for homologous use. The company adheres to AATB and FDA guidelines. Learn more at Regenative’s website: www.regenativelabs.com

 

About Dr. Michael Lavor: Dr Michael Lavor has worked for over 28 years bringing the highest quality of medicine to his patients. He is currently based out of Arizona, and is planning to open his own practice within the first 2 quarters of 2023. In addition to his work as Assistant Medical Director at Saguaro Surgical, Dr. Lavor was a member of the Trauma Team at Tucson Medical Center where he also served as Chairman of the Department of General and Vascular Surgery. Dr. Lavor was board certified in General Surgery and was a fellow in the American College of Surgeons, past president of the Rocky Mountain Vascular Surgical Society, a Fellow in the Southwestern Surgical Congress, a member of the Tucson Surgical Society, a member of the International Society of Endovascular Surgery and the Pima County Medical Society. Lavor served in the Navy for ten years as a Navy Corpsman with the Marines; he returned to service in 2009 and served as a Commander / OIC of a wound surgical base in Afghanistan from 2012-2013. He also was a Clinical Associate Professor at the University of Arizona Medical Center Department of Surgery.

This article was originally published here

HMP Global’s SAWC Spring | WHS announces record number of wound care abstract submissions for 2023 meeting

More than 500 abstracts featuring late-breaking wound care research, new advances and techniques to improve care and outcomes for patients were submitted for poster at the 2023 event, co-located with the Diabetic Limb Salvage meeting.

 

HMP Global, the leading omnichannel healthcare events and education company, today announced that its 2023 Symposium on Advanced Wound Care (SAWC) Spring and Wound Healing Society (WHS) received a record-breaking number of abstract submissions for the event taking place April 26-30, strengthened by a new partnership co-locating the symposium with the Diabetic Limb Salvage conference.

 

Now in its 36th year, SAWC Spring | WHS is the leading meeting dedicated to the research, management, treatment, and prevention of wounds; and through the partnership with DLS, this year’s event will feature more limb salvage-focused topics on the conference agenda. The meeting is the premier multidisciplinary forum to connect practitioners, researchers, and students with the foremost experts in wound care to improve patient outcomes through education.

 

Symposium participants will have access to 450 posters featuring late-breaking wound care research, new advances, strategies, and techniques to improve care and outcomes for patients. More than 500 abstracts — a record number — were submitted to undergo the peer review process for poster consideration.

 

In addition to presenting posters in person at SAWC Spring | WHS | DLS, wound care researchers can elevate their work further by submitting abstracts for publication in the field’s preeminent, peer-reviewed journal WOUNDS, focusing on the latest advances in wound care and wound research. WOUNDS is indexed in MEDLINE/PubMED and publishes research and commentary on tissue repair and regeneration, biology and biochemistry of wound healing, and clinical management of various wound etiologies. Submission information and guidelines are available on HMP Global’s Wound Care Learning Network.

 

“The record-breaking number of abstract submissions this year is a testament to the dedication of the wound care community to advancing their knowledge and skills,” said Tiffney Oliver, Vice President, Wound Care Learning Network, HMP Education. “For our 2023 meeting, we are excited to offer a world-class lineup of educational sessions as well as a record number of abstracts about the latest research in wound care.”

 

Submitted abstracts are blind reviewed by a panel of expert judges, based on specific criteria for the category in which it was submitted. Researchers may also be considered for poster grand rounds, oral abstracts, SAWC Young Investigator, and highest scoring abstract honors.

 

“We are excited to host one symposium for every member of the wound care team, allowing us to provide the highest caliber training and education that all clinicians can incorporate into their practice,” said WHS President Dr. Kenneth Liechty, Division Chief of Pediatric Surgery and Director of Fetal Medicine, University of Arizona, and Surgeon in Chief of Diamond Children’s Hospital. “The quantity and high caliber of the posters presented this year spotlights the most up-to-date research on wound care and limb salvage. This level of exposure to innovation is unparalleled in the wound care community.”

 

Posters will be on view from 7:30 a.m. to 5 p.m. Friday, April 28, and from 7:30 a.m. to 5 p.m. Saturday, April 29. In addition, SAWC Spring | WHS | DLS participants will have the opportunity to interact with the researchers during the Poster Reception and Awards Presentation from 7:15-8:30 p.m. on April 28, presented by WOUNDS.

 

Educational Program

The SAWC Spring | WHS | DLS agenda features more than 80 high-impact sessions from expert presenters led by the giants and emerging voices in the field, providing more than 25 CME/CE credits. Participants will have access to sessions in traditional as well as new formats, including hands-on workshops, rapid-fire, case-based, and patient panels. Learning tracks encompass the business of wound care as well as separate tracks through DLS and WHS.

 

“We have partnered with the Wound Healing Society for 15 years, providing a robust educational experience for meeting participants, and this year will be even stronger with the addition of multiple topics on amputation prevention, said SAWC Spring Co-Chair Dr. Robert S. Kirsner, Harvey Blank Professor and chairman, Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine. “No other wound care conference offers this level of education, advanced state-of-the-art clinical reviews, and emerging research findings.”

 

The interdisciplinary agenda is designed for every aspect of wound research, prevention, and healing, with an important focus on limb salvage. Sessions are designed for all members of the wound care team, including physicians, nursing professionals, podiatrists, physician assistants, physical therapists, researchers, scientists, dietitians, and healthcare, sales, and marketing professionals.

 

For more information or to register, visit sawcspring.com.

 

ABOUT HMP GLOBAL
HMP Global is the force behind Healthcare Made Practical — and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events — in person and online via its proprietary VRTX virtual platform — and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; Psych Congress, the largest independent mental health meeting in the U.S.; the Evolution of Psychotherapy, the world’s largest independent educational event for mental health professionals; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

 

This article was originally published here

Posted in Articles

Wound Masterclass – Emerging Technologies in Clinical Practice

by on

Negin Shamsian, Chien-Chung Shih, Madelyn R. Larson, Alana M. Mermin-Bunnell, Smiti Mitta, Jian-Cheng Lail, Aref Saberil, Ethan Beard, Serena Jing, Donglai Zhong, Sydney R. Steele, Kefan Sunl, Tanish Jain, Eric Zhaol, Christopher R. Neimeth, Willian G. Viana, Jing Tang, Dharshan Sivaraj, Jagannath Padmanabhan, Melanie Rodrigues, David P. Perrault, Arhana Chattopadhyay, Zeshaan N. Maan, Melissa C.…

Continue reading →